recombinant anti-HER2 humanized monoclonal antibody for injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant anti-HER2 humanized monoclonal antibody for injection, covering 2021-03-03 to 2021-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection [Phase 1, Phase 2]